FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023985405> ?p ?o ?g. }

• W2023985405 endingPage "436" @default.
• W2023985405 startingPage "426" @default.
• W2023985405 abstract "Pancreatic exocrine insufficiency (PEI) results in maldigestion, leading to abdominal pain, steatorrhoea, malnutrition and weight loss.To assess the efficacy and safety of pancreatin (Creon 40000 MMS) in treating PEI due to chronic pancreatitis (CP).This was a 1-week, double-blind, randomised, placebo-controlled, parallel-group, multicentre study in India. Men and women ≥18 years of age with proven CP and PEI [defined as a coefficient of fat absorption (CFA) ≤80% during run-in phase] were randomised 1:1 to pancreatin or placebo (two capsules orally per main meal, one with snacks). The primary outcome measure was change in CFA from baseline to end of double-blind treatment (analysis of covariance).Of 62 patients randomised (34 pancreatin, 28 placebo), 61 completed treatment; one patient in the placebo arm withdrew consent before completion. Patient characteristics were similar in both groups except for the proportion of men (pancreatin 82% vs. placebo 68%). Patients receiving pancreatin had a statistically significant greater improvement in fat absorption from baseline to the end of double-blind treatment compared with those receiving placebo, with a least squares mean change (95% CI) in CFA of 18.5% (15.8-21.2) vs. 4.1% (1.0-7.2), respectively. This resulted in a treatment difference of 14.4% (10.3-18.5); P = 0.001. Patients receiving pancreatin also had a statistically significant greater improvement in nitrogen absorption and greater reductions in mean stool fat, stool frequency and stool weight compared with those receiving placebo. Treatment-emergent adverse events occurred in 12 patients on pancreatin and in seven on placebo; none led to study discontinuation.The results provide evidence for the efficacy of pancreatin (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis, and confirm that this formulation is well tolerated, with a good safety profile, at the dose administered." @default.
• W2023985405 created "2016-06-24" @default.
• W2023985405 creator A5002367711 @default.
• W2023985405 creator A5016421302 @default.
• W2023985405 creator A5019699189 @default.
• W2023985405 creator A5032131607 @default.
• W2023985405 creator A5054419163 @default.
• W2023985405 creator A5064441978 @default.
• W2023985405 creator A5069901037 @default.
• W2023985405 creator A5087851465 @default.
• W2023985405 date "2012-07-04" @default.
• W2023985405 modified "2023-10-13" @default.
• W2023985405 title "Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind, placebo-controlled study" @default.
• W2023985405 cites W1426259424 @default.
• W2023985405 cites W1564544043 @default.
• W2023985405 cites W1965738864 @default.
• W2023985405 cites W1967449094 @default.
• W2023985405 cites W1968955399 @default.
• W2023985405 cites W1971316765 @default.
• W2023985405 cites W1990814447 @default.
• W2023985405 cites W1991724550 @default.
• W2023985405 cites W2014927084 @default.
• W2023985405 cites W2022687215 @default.
• W2023985405 cites W2031968580 @default.
• W2023985405 cites W2050357023 @default.
• W2023985405 cites W2051745786 @default.
• W2023985405 cites W2055855735 @default.
• W2023985405 cites W2084097643 @default.
• W2023985405 cites W2086815301 @default.
• W2023985405 cites W2089970850 @default.
• W2023985405 cites W2124109192 @default.
• W2023985405 cites W2133349101 @default.
• W2023985405 cites W2144114784 @default.
• W2023985405 cites W2147892054 @default.
• W2023985405 cites W2149787927 @default.
• W2023985405 cites W2157276282 @default.
• W2023985405 cites W4211115676 @default.
• W2023985405 doi "https://doi.org/10.1111/j.1365-2036.2012.05202.x" @default.
• W2023985405 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3528066" @default.
• W2023985405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22762290" @default.
• W2023985405 hasPublicationYear "2012" @default.
• W2023985405 type Work @default.
• W2023985405 sameAs 2023985405 @default.
• W2023985405 citedByCount "56" @default.
• W2023985405 countsByYear W20239854052012 @default.
• W2023985405 countsByYear W20239854052013 @default.
• W2023985405 countsByYear W20239854052014 @default.
• W2023985405 countsByYear W20239854052015 @default.
• W2023985405 countsByYear W20239854052016 @default.
• W2023985405 countsByYear W20239854052017 @default.
• W2023985405 countsByYear W20239854052018 @default.
• W2023985405 countsByYear W20239854052019 @default.
• W2023985405 countsByYear W20239854052020 @default.
• W2023985405 countsByYear W20239854052021 @default.
• W2023985405 countsByYear W20239854052022 @default.
• W2023985405 crossrefType "journal-article" @default.
• W2023985405 hasAuthorship W2023985405A5002367711 @default.
• W2023985405 hasAuthorship W2023985405A5016421302 @default.
• W2023985405 hasAuthorship W2023985405A5019699189 @default.
• W2023985405 hasAuthorship W2023985405A5032131607 @default.
• W2023985405 hasAuthorship W2023985405A5054419163 @default.
• W2023985405 hasAuthorship W2023985405A5064441978 @default.
• W2023985405 hasAuthorship W2023985405A5069901037 @default.
• W2023985405 hasAuthorship W2023985405A5087851465 @default.
• W2023985405 hasBestOaLocation W20239854051 @default.
• W2023985405 hasConcept C126322002 @default.
• W2023985405 hasConcept C141071460 @default.
• W2023985405 hasConcept C142724271 @default.
• W2023985405 hasConcept C168563851 @default.
• W2023985405 hasConcept C197934379 @default.
• W2023985405 hasConcept C202061045 @default.
• W2023985405 hasConcept C204787440 @default.
• W2023985405 hasConcept C27081682 @default.
• W2023985405 hasConcept C2775967933 @default.
• W2023985405 hasConcept C2776670229 @default.
• W2023985405 hasConcept C2777152358 @default.
• W2023985405 hasConcept C2779802037 @default.
• W2023985405 hasConcept C2991744798 @default.
• W2023985405 hasConcept C71924100 @default.
• W2023985405 hasConcept C90924648 @default.
• W2023985405 hasConceptScore W2023985405C126322002 @default.
• W2023985405 hasConceptScore W2023985405C141071460 @default.
• W2023985405 hasConceptScore W2023985405C142724271 @default.
• W2023985405 hasConceptScore W2023985405C168563851 @default.
• W2023985405 hasConceptScore W2023985405C197934379 @default.
• W2023985405 hasConceptScore W2023985405C202061045 @default.
• W2023985405 hasConceptScore W2023985405C204787440 @default.
• W2023985405 hasConceptScore W2023985405C27081682 @default.
• W2023985405 hasConceptScore W2023985405C2775967933 @default.
• W2023985405 hasConceptScore W2023985405C2776670229 @default.
• W2023985405 hasConceptScore W2023985405C2777152358 @default.
• W2023985405 hasConceptScore W2023985405C2779802037 @default.
• W2023985405 hasConceptScore W2023985405C2991744798 @default.
• W2023985405 hasConceptScore W2023985405C71924100 @default.
• W2023985405 hasConceptScore W2023985405C90924648 @default.
• W2023985405 hasIssue "5" @default.
• W2023985405 hasLocation W20239854051 @default.
• W2023985405 hasLocation W20239854052 @default.

• next